SEARCH test and treat study in Uganda and Kenya exceeds the UNAIDS 90-90-90 cascade target by achieving over 80% population-level viral suppression after.

Slides:



Advertisements
Similar presentations
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Advertisements

The HIV Engagement in Care Cascade Edward Gardner, MD Associate Professor of Medicine Denver Public Health University of Colorado Denver.
PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth Kapogiannis B, Leister E,
Characteristics of clients undergoing repeat HIV counseling and testing compared to clients newly-tested for HIV in Nyanza Province Oyaro P, Owuor K, Ng’eno.
Fast-track to ending AIDS in Zimbabwe: opportunities
Impact of a male centered rapid results initiative approach on PMTCT services in FACES supported MOH facilities in Nyanza Province Akama.
Changes in population-level HIV RNA distribution one year after implementation of key components of an HIV ‘test and treat’ strategy in rural Uganda Vivek.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Outcomes of newly diagnosed HIV- infected patients referred to care after Provider Initiated.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The United Kingdom provides excellent access and quality of.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
Integrated Community HIV Testing Campaigns: Leveraging HIV infrastructure for non- communicable diseases July 23, 2012 Gabriel Chamie, Dalsone Kwarisiima,
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
Expert Patients and AIDS Ministry of HealthMSF-OCB Mozambique CDC From Field Operational Research to National Roll Out of CASG in Mozambique.
MASIVUKENI: A Multimedia ART Initiation and Adherence Intervention for Resource-Limited Settings Robert H. Remien, Claude A. Mellins, Reuben Robbins, Hetta.
Boston University Slideshow Title Goes Here Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without.
Provision of streamlined HIV care associated with reduced economic burden of care-seeking among HIV-infected adults Aleksandra Jakubowski, Jane Kabami,
#AIDS2016 Index Client Trailing: a Home-Based HIV Counselling and Testing Strategy to Identify and Link People Living with HIV to.
Correlates of being outside the cascade among adults aged years in Zimbabwe: Results from the Zimbabwe Population-based HIV.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
New WHO Guidelines on Person centred monitoring
Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia.
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
PRESENTED AT THE 9TH IAS CONFERENCE ON HIV SCIENCE - PARIS, FRANCE
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
“Early Adopters” of PrEP in SEARCH study in rural Kenya and Uganda
Gaps in the cascade of care in two high prevalence settings in Zimbabwe and Malawi Nolwenn Conan1, Cyrus Paye2, Erica Simons2, Abraham Mapfumo3, Tsitsi.
Participants 18year old+
HIV treatment cascade analysis for people who inject drugs in Ukraine: identifying the correlates of HIV care outcomes Kostyantyn Dumchev1, Olga Varetska2,
Statewide Health Information Network of New York (SHIN-NY) and Regional Health Information Organizations (RHIOs) Institute for Implementation Science in.
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
Ambassador Deborah L. Birx, MD
Conclusions Background Results Acknowledgements: Methods
Richard hayes London school of hygiene & Tropical Medicine
MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,
Katharina Hauck On behalf of the HPTN 071 Study Team
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
The Cost of Differentiated Service Delivery: A Systematic Review
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Prevention of mother to child transmission and early infant diagnosis in Malawi: Accomplishments of a mature Option B+ program in a resource-limited setting.
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Centre for International Health, University of Bergen, Norway
IMPLEMETNATION OF PrEP IN SRH SETTINGS (OR CLIMBING A MOUNTAIN)
Division of Global HIV & TB
From trials to programmes: Lessons learned from four trials of Universal Testing and Treatment (UTT) in Sub-Saharan Africa 24th July 2018 Estimates of.
Where are the coverage gaps? Data from the four UTT trials
Management and Development for Health (MDH)
Needs Assessment Slides for Module 4
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
No conflict of interest to declare
Stakeholder engagement and research utilization: Insights from Namibia
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
Knowledge of HIV Status in Kenya
Increased levels of alcohol use are associated with worse HIV care cascade outcomes among adults in Kenya and Uganda Sarah Puryear, MD, MPH University.
Presentation transcript:

SEARCH test and treat study in Uganda and Kenya exceeds the UNAIDS cascade target by achieving over 80% population-level viral suppression after 2 years M. Petersen, L. Balzer, D. Kwarsiima, N. Sang, G. Chamie, J. Ayieko, J. Kabami, A. Owaraganise, T. Liegler, F. Mwangwa, K. Kadede, V. Jain, A. Plenty, G. Lavoy, D. Black, E. Bukusi, C. Cohen, T. Clark, E. Charlebois, M. Kamya, D. Havlir

Thank you to UNAIDS, PEPFAR, NIH, WHO for support My great appreciation for all who work on SEARCH, our multilateral partners, funders and the communities we serve PIs: Diane Havlir, Moses Kamya, Maya Petersen Statistician: Laura Balzer, Mark van der Laan Vice-Chair: Edwin Charlebois Virologist: Teri Liegler KEMRI: Elizabeth Bukusi, NortonSang, James Ayieko, Kevin Kadeke KEMRI:/UCSF: Craig Cohen MU-UCSF: Dalsone Kwarisiima, Jane Kabami, Asiphas Owaraganise, Florence Mwangwa, Tamara Clark, Gabe Chamie, Starley Shade, Vivek Jain, Carol Camlin, Mucu Atukunda SEARCH

Background ART for treatment and prevention has potential to dramatically alter the trajectory of the epidemic To realize this benefit, effective scalable strategies are needed to optimize each step of HIV care cascade 1.Diagnosing all HIV+ 2.Initiating ART among all diagnosed HIV+ 3.Virally Suppressing all HIV+ on ART

SEARCH Study Ongoing cluster randomized trial to evaluate an HIV “test and treat” strategy – 32 communities; ~10,000 residents in each 12 Kenya, 10 Western Uganda, 10 Eastern Uganda Intervention: 1.Annual community-based HIV & multi disease testing 2.Universal ART eligibility with streamlined care NCT:

#AIDS2016 SEARCH Testing Intervention: Annual Community-Based Testing Goal: >90% HIV testing Approach: –Community based, out of facility –Multi-disease: HIV, DM, HT, malaria –“Collapse the Cascade”- immediate link to public health services 1.Census/Mobilization 2.Two week Health Fair 3.Home testing for non-participants Chamie, Lancet HIV 2016

SEARCH Treatment Intervention: Universal Streamlined ART Delivery 1. Efficient Visits for Patients and Staff ART start at first clinic visit as indicated Triage by nurse or other extender at all follow-up visits Clinic visits and ART dispensation every 3 months rather than every 1-2 months 2. Patient-centered approach to care Welcoming environment Fostering trust, connection, and a sense of investment in the patient Flexible clinic hours Tiered Tracking Multi-disease chronic care model 3. Telephone hotline access for patients Easy triage of medical questions Appointment/scheduling logistics for retention 4. Appointment reminders by phone/SMS One week to few days in advance Retention tool 5. Viral Load Counseling Structured format for discussion of undetectable and detectable results Jain et al., AIDS, 2014 Kwarisiima et al., CROI 2016

Objectives of this Analysis Characterize evolution in HIV care cascade in SEARCH intervention communities – Baseline, follow up year 1, and follow up year 2 annual testing campaigns 1.Cascade among all prevalent HIV+ community residents – Serial cross-sectional 2.Cascade among residents who tested HIV+ at baseline – Longitudinal cohort

UNAIDS Target This Analysis: Suppression = plasma HIV RNA< 500 cps/ml

Population & Measures Inclusion Criteria: – Adult (>=15 years at baseline) – Stable resident (>6 months/past year) of one of 16 SEARCH intervention communities – Enumerated in baseline census Population-based measures – Demographics at baseline census – HIV serostatus and plasma HIV RNA level measured at annual community-based testing – Prior HIV care, including ART measured through linkage to clinic records

Statistical Analyses Inverse weights/Targeted maximum likelihood to adjust for 1.Incomplete ascertainment of prevalent HIV+ 2.Incomplete HIV RNA measures 3.Censoring by death/migration (longitudinal analyses) Restriction to 11/16 communities with two full years follow up when estimating 1.Year 2 cascade among prevalent HIV+ 2.Longitudinal analyses of baseline HIV+

Baseline Characteristics KenyaW UgandaE UgandaTotal Stable adults (N)27,64025,01325,12077,773 HIV+20.1%6.5%3.5%10.3% Male44%47%45% Age years33%34%38%35% years24%23%21%23% >34 years32%43%41%42% Occupation Farmer43%55%62%53% Fisher7%0%0.2%3% Student21%18%20% No job7%5%3%5% >1mo past year away 4%10%8%

UN AIDS Target Exceeded UNAIDS Target

Year 2: >80% HIV+ Virally Suppressed UNAIDS Target

Cascade by Gender

Cascade by Age

Cascade Evolution Among Subjects Tested HIV+ at Baseline Viral Suppression Viral Failure Prior Dx, no ART Migrated New Diagnosis Died

Cascade Evolution Among Men Tested HIV+ at Baseline Viral Suppression Viral Failure Prior Dx, no ART Migrated New Diagnosis Died

Cascade Evolution Among Youth Tested HIV+ at Baseline Viral Suppression Viral Failure Prior Dx, no ART Migrated New Diagnosis Died

Viral Suppression Over Time Among Baseline HIV+

Conclusions Population viral suppression increased from 48% to 82% during two years of the SEARCH intervention Baseline lower suppression in men and youth – After two years of intervention, disparity among men reduced – Suppression remains below target in youth SEARCH Study poised to evaluate the impact of achieving the UNAIDS target on HIV incidence, health, education and economic outcomes. – Primary Endpoint: Paris 2017

Funding Research reported in this presentation was supported by Division of AIDS, NIAID of the National Institutes of Health under award number U01AI and in part by the President’s Emergency Plan for AIDS Relief and Gilead Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, PEPFAR, or Gilead. The SEARCH project gratefully acknowledges the Ministries of Health of Uganda and Kenya, our research team, collaborators and advisory boards, and especially all communities and participants involved. Thank you!